Skip to content

Clinical trials

Phase 2 Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 2 Country / region: United States Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20031
20046
20054
20063
200713
20087
20097
20105
20116
201212
20136
20148
20156
20167
20177
20189
20197
20204
20215
20227
20233
20243
20258
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Terminated22
Recruiting14
Withdrawn7
Active, not recruiting6
Not yet recruiting5
Unknown status5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals12
University of Texas Southwestern Medical Center6
Alnylam Pharmaceuticals4
Emory University4
Ionis Pharmaceuticals, Inc.4
Vanderbilt University Medical Center4
Alcon Research3
Mineralys Therapeutics Inc.3
NYU Langone Health3
University of Alabama at Birmingham3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension165
Obesity14
Diabetes Mellitus12
Renal Insufficiency, Chronic12
Diabetes Mellitus, Type 210
Cardiovascular Diseases9
Kidney Diseases7
Metabolic Syndrome7
Dyslipidemias5
Hypercholesterolemia5

Trials

Showing 1 to 25 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.